Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 27Terminated 8Withdrawn 5Recruiting 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 2Sarcoma 1NET 1Lymphoid 1Gastrointestinal 1

Conditions

Sarcoma, Synovial 1Prolactin-Producing Pituitary Tumor 1Lymphoma, Follicular 1Gastro-enteropancreatic neuroendocrine tumor 1Desmoplastic Small Round Cell Tumor 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × pasireotide × Clear all
NCT06784752 2026-04-30

NETTER-3

Novartis

Phase 3 Recruiting
240 enrolled
EndocrineGastrointestinalLymphoidNET

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
10 enrolled
Endocrine

Prolactin-Producing Pituitary Tumor

NCT06456359 2025-01-13

PAMSARC

University Hospital Heidelberg

Phase 2 Recruiting
28 enrolled
Sarcoma

Sarcoma, Synovial, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡